Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Aβ(1-42) and rapid scrapie disease development

International Journal of Developmental Neuroscience

Volumn 26, Issue 7, 2008, Pages 821-824

  Baier, Michael ^a   Apelt, Jenny ^b   Riemer, Constanze ^a   Gültner, Sandra ^a   Schwarz, Anja ^a   Bamme, Theresa ^a   Burwinkel, Michael ^a   Schliebs, Reinhard ^b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Amyloid; Secretase; Alzheimer; APP processing; Prion

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; FORMIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; GLIOSIS; MOUSE; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; SCRAPIE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CEREBRAL CORTEX; FORMIC ACIDS; GLIOSIS; HUMANS; MICE; MICE, TRANSGENIC; NERVE DEGENERATION; NEUROCHEMISTRY; PEPTIDE FRAGMENTS; PRION DISEASES; PRIONS; PRPSC PROTEINS; SCRAPIE; SENILE PLAQUES; SURVIVAL RATE; UP-REGULATION;

ANIMALIA; MUS;

EID: 53049096541     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2008.07.001     Document Type: Article

References (15)

1. Apelt J., Bigl M., Wunderlich P., and Schliebs R. Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology. International Journal of Development Neuroscience 22 (2004) 475-484
2. Barnham K.J., Cappai R., Beyreuther K., Masters C.L., and Hill A.F. Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends in Biochemical Sciences 31 (2006) 465-472
3. Burwinkel M., Schwarz A., Riemer C., Schultz J., van Landeghem F., and Baier M. Rapid disease development in scrapie-infected mice deficient for CD40 ligand. EMBO Reports 5 (2004) 527-531
4. Del Bo R., Scarlato M., Ghezzi S., Martinelli-Boneschi F., Fenoglio C., Galimberti G., Galbiati S., Virgilio R., Galimberti D., Ferrarese C., Scarpini E., Bresolin N., and Comi G.P. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiology of Aging 27 (2006) 770 e771-770 e775
5. Hainfellner J.A., Wanschitz J., Jellinger K., Liberski P.P., Gullotta F., and Budka H. Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathologica 96 (1998) 116-122
6. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science (New York, NY) 274 (1996) 99-102
7. Hsiao K.K. Understanding the biology of beta-amyloid precursor proteins in transgenic mice. Neurobiology of Aging 16 (1995) 705-706
8. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., and Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. Journal of Neuroscience 21 (2001) 372-381
9. Mucke L., Yu G.Q., McConlogue L., Rockenstein E.M., Abraham C.R., and Masliah E. Astroglial expression of human alpha(1)-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice. The American Journal of Pathology 157 (2000) 2003-2010
10. Parkin, E.T., Watt, N.T., Hussain, I., Eckman, E.A., Eckman, C.B., Manson, J.C., Baybutt, H.N., Turner, A.J., Hooper, N.M., 2007. Cellular prion protein regulates betasecretase cleavage of the Alzheimer's amyloid precursor protein. Proceedings of the National Academy of Sciences of the United States of America, vol. 104. pp. 11062-11067.
11. Riemer C., Neidhold S., Burwinkel M., Schwarz A., Schultz J., Kratzschmar J., Monning U., and Baier M. Gene expression profiling of scrapie-infected brain tissue. Biochemical and Biophysical Research Communications 323 (2004) 556-564
12. Schmitt-Ulms G., Hansen K., Liu J., Cowdrey C., Yang J., DeArmond S.J., Cohen F.E., Prusiner S.B., and Baldwin M.A. Time-controlled transcardiac perfusion cross-linking for the study of protein interactions in complex tissues. Nature Biotechnology 22 (2004) 724-731
13. Schultz J., Schwarz A., Neidhold S., Burwinkel M., Riemer C., Simon D., Kopf M., Otto M., and Baier M. Role of interleukin-1 in prion disease-associated astrocyte activation. The American Journal of Pathology 165 (2004) 671-678
14. Schwarze-Eicker K., Keyvani K., Gortz N., Westaway D., Sachser N., and Paulus W. Prion protein (PrPc) promotes beta-amyloid plaque formation. Neurobiology of Aging 26 (2005) 1177-1182
15. Voigtlander T., Kloppel S., Birner P., Jarius C., Flicker H., Verghese-Nikolakaki S., Sklaviadis T., Guentchev M., and Budka H. Marked increase of neuronal prion protein immunoreactivity in Alzheimer's disease and human prion diseases. Acta Neuropathologica 101 (2001) 417-423